Most people come here because a hospital somewhere else in Japan has run out of a clear answer. That shapes what this place is built to do. It performs about 5,600 operations a year across 17 operating rooms. It sees around 1,400 outpatients a day. A large share of that work involves cancers that are advanced, unusual in type, or already treated once without success. Care is organized by organ rather than by type of treatment. So a patient with esophageal cancer is seen by the surgeon, the cancer drug doctor, and the radiation doctor who spend their careers on esophageal cancer. They talk the case through together once, instead of giving three separate opinions.
The rare cancer problem is worth explaining. It is much of the reason a hospital like this exists. A rare cancer is usually defined as one that appears in fewer than 6 people per 100,000 each year. Each type on its own is uncommon. But added together, the rare types make up a large share of all new cancer diagnoses. So a large number of patients have a disease their local pathologist may have seen once or twice in a whole career. A pathologist is the doctor who examines the tumor sample and names the disease. The Rare Cancer Center opened in 2014 and gathers those cases in one place. The diagnosis is then confirmed by people who see that tumor type regularly. The center also builds national networks for diagnosing and treating these cancers. And it writes information for patients, because many rare cancers have almost nothing written about them in plain language.
Early cancers of the esophagus, stomach, and colon bring a different problem. A tumor that has grown only into the innermost layers of the gut wall can still be cured. But the traditional cure is removing a large part of the organ. Endoscopic submucosal dissection avoids that trade. An endoscope is a thin tube with a camera on the end. It is passed in through the mouth or from below. The tumor is lifted away from the deeper layers and cut out in one piece. The organ stays in place. The hospital's endoscopy division does a high volume of this work. It also runs the national trials that decide who should be offered it. One of those trials studies the procedure for early gastric cancer in elderly patients. Another compares steroid tablets against steroid injected into the site. Both are ways to prevent the narrowing of the esophagus that can follow the procedure.
The usual main services sit alongside all of that. There is radiation treatment. There is a large outpatient chemotherapy center, where drug treatment is given without staying overnight. There are separate pathology and clinical laboratory divisions, which any gene testing program depends on. And there is palliative and supportive care, which Japan requires of every designated cancer hospital. Palliative care treats pain and other symptoms rather than the cancer itself. This hospital writes the treatment guidance used across Japan. So the plan a patient gets here is usually the same one a regional hospital would follow. The difference is that it is given by the teams who wrote it, and who see the hardest versions of the case.